<DOC>
	<DOC>NCT00813397</DOC>
	<brief_summary>This study will examine the performance of SeprasSpray in patients undergoing abdominal surgery (laparoscopic).</brief_summary>
	<brief_title>Manageability and Safety Assessment of Sepraspray in Abdominal Surgery.</brief_title>
	<detailed_description />
	<mesh_term>Tissue Adhesions</mesh_term>
	<criteria>Patients 18 years old and over that require laparoscopic abdominal surgery Patients who are pregnant or have an ongoing infectious complications from a previous surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>